In response to an increase in Covid cases in schools, the Drugs Controller General of India (DCGI) today granted Bharat Biotech’s Covaxin restricted use authorization for children aged 6 to 12. The DCGI gave its approval following recommendations from the Central Drugs Standard Control Organisation’s Subject Expert Committee (SEC) on COVID-19 (CDSCO). For the Continue Reading
